| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00 |
| filingDate |
2002-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4610b0e34a1b9acb5d05cb64931e6f89 |
| publicationDate |
2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004109899-A1 |
| titleOfInvention |
Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases |
| abstract |
There is disclosed a prophylactic and therapeutic antiviral composition and in particular compositions which comprise containing vertebrates kidney as a main component. Use of the composition through parenteral administration for the prevention and treatment of viral-induced tumors, lesions and diseases in mammals such as humans or to prepare a medicament is also disclosed. The composition is very effective in preventing and treating viral infections and manifestations as hyperplasia, keratosis, and dermatosis and in particular those caused by Papillomavirus and more particularly Human Papillomavirus. Among the many benefits, the present compounds provide high remedial effect and complete resolution in a relatively short course of treatment with no risk of side effects what so ever. The composition is abundant, inexpensive, easily prepared, and may be self administered to the afflicted area by the patients themselves. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111053883-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104971266-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014011839-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110498852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7858126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009263454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008058413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007003915-A1 |
| priorityDate |
2002-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |